These effects are seen even outside of diabetes control.[ref] Decreased colon cancer mortality: A 5-year mortality study in colon cancer patients showed that GLP-1 RA use decreased mortality risk by 60% in obese patients.[ref] Decreased risk of substance abuse: A large 2026 study using data from the VA showed that GLP-1 RA drugs reduce the risk of developing a substance addiction (drugs, alcohol)
Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy
doi:10.1111/j.1365-2982.2010.01476.x Panjwani N, Mulvihill EE, Longuet C, et al
GLP patch reviews are everywhere, and many sound confident, mentioning less snacking, fewer cravings, and quick early weight changes
How do they compare to true GLP-1 medications
Then, we create high-priced drugs that mimic our satiety response to nutritious food